Alkem Labs shareholders approve Adroit Biomed amalgamation with 99.99% votes
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alkem Laboratories held its NCLT-convened equity shareholders meeting on August 17, 2026 to approve the scheme of amalgamation with Adroit Biomed Limited. Shareholders voted overwhelmingly in favor at 99.9999%, with over 99.98 million valid votes polled on total outstanding shares. The special resolution was passed with the requisite majority under Sections 230-232 of the Companies Act, 2013. The scheme now moves toward NCLT sanction and other regulatory approvals before becoming effective.
Shareholders have approved Adroit Biomed's merger into Alkem. The deal now moves toward NCLT sanction and other regulatory clearances before taking effect.